Akash Malhotra

ORCID: 0000-0002-9298-0936
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Pneumonia and Respiratory Infections
  • HIV/AIDS Research and Interventions
  • Health Policy Implementation Science
  • Health Systems, Economic Evaluations, Quality of Life
  • Mycobacterium research and diagnosis
  • Radiomics and Machine Learning in Medical Imaging
  • Chronic Disease Management Strategies
  • Biosimilars and Bioanalytical Methods
  • Congenital gastrointestinal and neural anomalies
  • Global Maternal and Child Health
  • Diagnosis and treatment of tuberculosis
  • Biomedical and Engineering Education
  • Antibiotic Resistance in Bacteria
  • Gastrointestinal motility and disorders
  • HIV, Drug Use, Sexual Risk
  • Adolescent Sexual and Reproductive Health
  • Infant Health and Development
  • AI in cancer detection
  • Primary Care and Health Outcomes
  • Genomics and Rare Diseases
  • COVID-19 diagnosis using AI
  • Pneumocystis jirovecii pneumonia detection and treatment

University of Washington
2025

Foundation for Innovative New Diagnostics
2024

Johns Hopkins University
2022-2024

City University of Hong Kong
2021

10.1016/s2352-3018(24)00343-6 article EN The Lancet HIV 2025-02-01

Abstract Introduction In high-burden settings, low-complexity screening tests for tuberculosis (TB) could expand the reach of community-based case-finding efforts. The potential costs and cost-effectiveness approaches incorporating these are poorly understood. Methods We developed a microsimulation model assessing 3 to in hypothetical populations (India-, South Africa-, Philippines-, Uganda-, Vietnam-like settings) with TB prevalence 4 times that national estimates: (1) point-of-care...

10.1093/cid/ciad501 article EN cc-by Clinical Infectious Diseases 2023-08-25
Chacha Mangu Marta Cossa Robert Ndege Celso Khosa Vinzeigh Leukes and 95 more Laura de la Torre‐Pérez António Machiana Bernard Kivuma Dorcas Mnzava Craysophy Zachariah Patricia Manjate Elisa Tagliani Claudia Schacht J. Buech Sunita Singh Joanna Ehrlich F. Rieß Sergi Sanz Katharina Kranzer Helen Cox Issa Sabi Dinis Nguenha Bindiya Meggi Maja Weisser Nyanda Elias Ntinginya Samuel G. Schumacher Morten Rühwald Adam Penn‐Nicholson Alberto L. García‐Basteiro Berra Erkoşar Muhuminu Nuru Mahmud Mahmud Neema Shija Deogratias Bulime Petro Sabuni Hosiana Temba Jamali Siru Jerry Hella Jonathan Msafiri Mohamed Mbaruku Mohamed Sasamalo A. S. Leonard Ambilikile Malango Annastazia Alexander Faith Komakoma Gloria Msigala Kasmir Johaness Grace Mhalu Mwajabu Hamis Priscilla Mlay Sera Barasa Swalehe Masoud Theonestina Byakuzana Anange Lwilla Pauline Sylvester Emanuel Sichone Subira Wailes Bariki Mtafya Abisai Kisinda M Martine Regino Mgaya Christina Manyama Theodora Mbunda Elimina Siyame Last Mwaipopo Nyanda Elias Ntinginya Raphael Edom Willyhelmina Olomi Délio Elísio Edson Mambuque Joaquim Cossa Neide Gomes Shilzia Munguambe Sozinho Acácio Hélio Chiconela Katia Ribeiro Carla Madeira Daniel Machavae Emelva Manhiça Onélia Guiliche Diosdélio Malamule Sofía Viegas Belén Saavedra Carlos Fernández‐Escobar Michael Hoelscher Norbert Heinrich Leyla Larsson María del Mar Castro Claudia M. Denkinger Saima Arif Daniela María Cirillo Federico Di Marco Virginia Batignani Akash Malhotra David W. Dowdy Caroline Stöhr Marguerite Massinga Loembé Pascale Ondoa Nqobile Ndlovu Fumbani Brown

Tuberculosis (TB) is an important cause of morbidity and mortality among people living with HIV (PLHIV). Current WHO-recommended strategies for diagnosing TB hospitalized PLHIV rely on symptom screening disease severity to assess eligibility urine lipoarabinomannan lateral flow (LF-LAM) molecular testing. Despite these recommendations, autopsy studies show a large burden undiagnosed admitted PLHIV. The EXULTANT trial aims the impact expanded strategy using three specimens (sputum, stool,...

10.1186/s12879-024-09651-z article EN cc-by-nc-nd BMC Infectious Diseases 2024-08-15

Abstract Background In settings with large case detection gaps, active case-finding (ACF) may play a critical role in the uberculosis (TB) response. However, ACF is resource intensive, and its effectiveness depends on whether people detected TB through might otherwise spontaneously resolve or be diagnosed routine care. We analysed potential of for relative to counterfactual scenario care alone. Methods constructed Markov simulation model natural history, diagnosis, symptoms, treatment, using...

10.1093/ije/dyae019 article EN International Journal of Epidemiology 2024-02-14

Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profiles suitable placement range TB laboratory tiers improve susceptibility (DST) coverage.We conducted cost analysis two MC-NAATs with different throughput: Lower Throughput (LT, < 24 per run) and Higher (HT, upto 90+ hypothetical...

10.1371/journal.pone.0290496 article EN cc-by PLoS ONE 2023-08-24

Functional intestinal imaging holds importance for the diagnosis and evaluation of treatment gastrointestinal diseases. Currently, preclinical motility in animal models is performed either invasively with excised intestines or noninvasively under anesthesia, cannot reveal dynamics awake condition. Capitalizing on near-infrared optics a high-absorbing contrast agent, we report Trans-illumination Intestine Projection (TIP) system free-moving mice. After complete evaluation, vivo studies,...

10.1038/s41467-021-21930-w article EN cc-by Nature Communications 2021-03-16

Abstract Background Each year, 1 million children develop TB resulting in over 200,000 child deaths. preventive treatment (TPT) is highly effective preventing but remains poorly implemented for household contacts. Home-based contact management and TPT services may improve access to care. In this study, we aim evaluate the effectiveness cost-effectiveness of home-based with initiation two high-burden African countries, Ethiopia South Africa. Methods This pragmatic cluster randomized trial...

10.1186/s13063-023-07514-7 article EN cc-by Trials 2023-07-25

Abstract Background In 2020, the WHO-approved Molbio Truenat platform and MTB assays to detect Mycobacterium tuberculosis complex (MTB) resistance rifampicin directly on sputum specimens. This primary health care center-based trial in Mozambique Tanzania investigates effect of platform/MTB (intervention arm) combined with rapid communication results compared standard TB diagnosis treatment initiation for microbiologically confirmed at 7 days from enrolment. Methods The Tuberculosis Close...

10.21203/rs.3.rs-3348643/v1 preprint EN cc-by-nc-sa Research Square (Research Square) 2023-10-03

Abstract Background Computer-aided detection (CAD) using artificial intelligence (AI) to analyze chest radiographs is an important tool for community tuberculosis (TB) screening in high burden countries. Most current algorithms use a universal cut-off score select individuals confirmatory TB testing; however, tailored based on client demographics (age and sex) may improve performance. Methods Community-based was conducted portable X-ray with CAD (qXR, [Qure.ai, India]) as part of...

10.1093/ofid/ofad500.105 article EN cc-by Open Forum Infectious Diseases 2023-11-27

<h3>Background</h3> Diagnostic testing for TB needs to optimize access, turnaround time and thus treatment initiation cost. Point of care (POC) optimizes the former, but additional costs beyond test cost alone might be drivers overall in a POC strategy, especially low-and-middle-income settings. <h3>Methods</h3> We estimated health system per participant tested on-site via novel Molbio Truenat MTB/RIF platform (Molbio Diagnostics, Verna, Goa, India) versus hub-and-spoke standard care,...

10.1136/bmjgh-2023-edc.24 article EN 2023-12-01
Coming Soon ...